Learn More
Bio X Cell Antibody, Human IgG4, Anti-C5, Eculizumab, 1 MG
Supplier: Bio X Cell SIM0011R001MG
This non-therapeutic biosimilar antibody utilizes the same variable regions as the therapeutic antibody Eculizumab, making it suitable for research. It reacts with human terminal complement component 5 (C5). Eculizumab inhibits the cleavage of C5 to C5α and C5β.
- Non-therapeutic biosimilar antibody
- Reacts with human terminal complement component 5 (C5)
- Inhibits the cleavage of C5
- Purified from cell culture supernatant in an animal-free facility
- Sterility confirmed by 0.2 μm filtration
- Low endotoxin level (≤0.5EU/mg)
- Low aggregation (<5%)
- High purity (≥95%)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.